Clinical Trial Update: Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares reduced-dose versus conventional-dose intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Ming-Yuan Chen | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 3 | Status: RECRUITING